Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Angus Chemical Company currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This active prosecution is handled by 1 distinct examiner and 1 distinct art unit, suggesting that the company's current workload is focused within a single technical niche at the USPTO. For a practitioner, there is no need to coordinate between different examiner styles or art unit policies. This concentration allows for a more efficient and unified prosecution strategy.
The busiest examiner for this portfolio is SAWYER, JENNIFER C, who is assigned 1 busiest examiner pending action. Since the total number of pending office actions is 1, SAWYER, JENNIFER C is the sole examiner currently reviewing the company's pending applications. This creates a streamlined prosecution process where the practitioner can focus on a single point of contact. The outcome of the current pending matter rests with SAWYER, JENNIFER C and the standards of the 1 distinct art unit. This singular focus reduces the complexity of managing the company's active intellectual property assets.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAWYER, JENNIFER C | 1 | 68.6% | -8.1% |
| Art Unit | Apps |
|---|---|
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17603905 | LOW TOXICITY ORGANIC TERTIARY AND QUATERNARY AMINES AND USES THEREOF | SAWYER, JENNIFER C | 1691 | §103 | Final Rejection | — | Pending | Oct 14, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAngus Chemical Company has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Jennifer C Sawyer has the most, with 1 of Angus Chemical Company's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.